Vir Biotechnology
VIR
VIR
203 hedge funds and large institutions have $2.09B invested in Vir Biotechnology in 2022 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 83 increasing their positions, 44 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 209 → 203 (-6)
36% less capital invested
Capital invested by funds: $3.25B → $2.09B (-$1.16B)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
203
Holding in Top 10
4
Calls
$16.7M
Puts
$10.3M
Top Buyers
| 1 | +$97.2M | |
| 2 | +$42.8M | |
| 3 | +$22.7M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$12.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11M |
Top Sellers
| 1 | -$86M | |
| 2 | -$36M | |
| 3 | -$30.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$24.7M |
| 5 |
Morgan Stanley
New York
|
-$16.4M |